• President of Venture Leader Group

  • Former President of TEEC Angel Fund 

  • Executive Vice President of Technology and Research, Microsoft

  • Chemistry at Vertex Pharmaceuticals

Management

Robert Perni, PhD

EXECUTIVE CHAIRMAN
  • 20+ years of experience in business development

  • ​Formerly at Johnson and Johnson, ImmunoGen, Anchor, and Oxyrane

Yeung Heung Yeung, PhD

  • Managing Director at Danforth Advisors with deep financial expertise

CFO (PART-TIME)
  • Cancer biology at AnorMed and Genzyme

Daniel Geffken, MBA

CORPORATE DEVELOPMENT, COO

Simon Fricker, PhD

  • Investment Director at Jianxin Capital

Paul D. Rennert, PhD

Eric Cheng, MD, MBA

WntRx's team is comprised of world-leading cancer researchers and biotech industry innovators whose work lies at the forefront of cancer therapeutics development. Management is guided by distinguished advisors, including industry leaders and highly experienced investors and entrepreneurs.

Jin (Jim) Wang

Advisors

CO-FOUNDER, CBO (PART-TIME)

Team

  • Immuno-oncology at Aleta, Biogen, and X-Rx

  • 20+ years of experience in founding, investing, and managing innovative therapeutic R&D companies

John Tagliamonte, MBA